Daily Archives: October 20, 2020
Efficacy and outcome of Tofacitinib in Immune checkpoint inhibitor colitis.
Cancer Screening during COVID-19: A Perspective from NCI’s PROSPR consortium
UPDATE: Exposure, post-infection and return-to-work FAQs
“My spouse/child/roommate/friend/etc. was in contact with someone who was positive. What do I do?” — and other questions. Continue reading
NEW: Clinical trial to test HIV drugs to treat COVID-19
Vanderbilt University Medical Center, in collaboration with the University of Colorado and Beth Israel Deaconess Medical Center in Boston, is leading one of the first “telemedicine” clinical trials to test a potential treatment for COVID-19. Continue reading
UPDATE: COVID-19 VUMC workforce exposure, post-infection, and return-to-work guidelines
Exposure is defined as interactions greater than 10 minutes and closer than 6 feet. Look for any new onset of respiratory or flu-like symptoms, including cough, shortness of breath, loss of smell or taste (without other neurologic symptoms), diarrhea, … Continue reading
REMINDER: Joint statement from Nashville hospitals about COVID-19
With increasing COVID-19 cases and a rising positivity rate in Middle Tennessee, Nashville’s four largest hospitals joined together this week to appeal to the citizens of the region to practice diligent hand hygiene, remain socially distanced and wear … Continue reading
NEW: VUMC’s Infection Prevention Team recognized for outstanding work
Vanderbilt University Medical Center’s Infection Prevention Team is being recognized for their outstanding contributions during this year’s battle against the COVID-19 pandemic. Continue reading
UPDATE: Weekly COVID-19 statistics
A snapshot of some of the numbers that help tell the story of COVID-19 at Vanderbilt. Continue reading